Notifications

Home

Stocks
- Stock Screener
- Market Movers
- Insider Trades
- Upcoming Earnings
- Upcoming Dividends
Options
- Unusual Options Activity
- Implied Volatility Rank
- Volatility %Change
News
Upcoming IPOs

Stablecoin Development Corp (SDEV)

$0.89 +0.03 (3.54%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	44.35M
Revenue (ttm)	0.00
Net Income (ttm)	-22.14M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	154,961
Avg Vol	1,240,558
Day's Range	N/A - N/A
Shares Out	50.62M
Stochastic %K	22%
Beta	0.16
Analysts	Strong Buy
Price Target	N/A

Company Profile

Stablecoin Development Corporation engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol. Its services intend to support protocol-level services, including staking, governance participation, validation, and related activities. The company was formerly known as NovaBay Pharmaceuticals, Inc. and changed its name to Stablecoi...

Industry: Asset Management

Sector: Financial Services

Phone: 510 899 8800

Fax: 510 474 1577

Website: stabledev.com

Address:

2000 Powell Street, Suite 1150, EmeryVille, United States

uddin Sep. 8 at 1:52 AM

$SDEV Buying opportunities

0 · Reply

uddin Sep. 5 at 7:10 AM

$SDEV $PWCM Bottom player both will go long way longer 🔥⏰💰

0 · Reply

uddin Sep. 4 at 11:41 PM

$SDEV will flow with $USDE 🔥

0 · Reply

giglio75 Sep. 3 at 2:46 PM

$SDEV 🗯

0 · Reply

uddin Sep. 1 at 3:34 PM

$USDE $SDEV Also more than something 🔥💰

0 · Reply

uddin Sep. 1 at 3:32 PM

$SDEV Hi guys it’s a Diamond stock big buying opportunity 🔥⏰

0 · Reply

Alshma1l Sep. 1 at 1:25 PM

$SDEV sky will hit 0.08-0.09 after 0.07200

0 · Reply

Stockinvestigator420 Aug. 28 at 1:01 AM

$USDE I also picked up some $SDEV. They do SKY tokens. Same shit. Still at the $1 area. USDE is Coke and SDEV is Pepsi…. 😂

0 · Reply

Stockinvestigator420 Aug. 28 at 12:07 AM

$SDEV

0 · Reply

Stock__Hunter Aug. 27 at 2:22 PM

$SDEV bounced off bottom trend yesterday

0 · Reply

Stablecoin Development Registration statement: Registration filing

Aug 3, 2026, 11:50 PM EDT - 5 weeks ago

SDEV: Abbott Cooper PLLC Announces Investigation on Behalf of Stablecoin Development Corporation (Formerly Novabay Pharmaceuticals, Inc.) Stockholders

Jul 31, 2026, 8:30 AM EDT - 6 weeks ago

Stablecoin Development Corporation Reports Second Quarter 2026 Financial Results

Jul 30, 2026, 7:00 AM EDT - 6 weeks ago

Stablecoin Development Quarterly report: Q2 2026

Jul 30, 2026, 7:00 AM EDT - 6 weeks ago

Stablecoin Development Earnings release: Q2 2026

Jun 17, 2026, 11:22 PM EDT - 2 months ago

SDEV: Abbott Cooper PLLC Announces Investigation on Behalf of Stablecoin Development Corporation (Formerly NovaBay Pharmaceuticals, Inc.) Stockholders

May 20, 2026, 8:30 AM EDT - 3 months ago

Stablecoin Development Corporation Reports First Quarter 2026 Financial Results

May 20, 2026, 8:30 AM EDT - 3 months ago

Stablecoin Development Quarterly report: Q1 2026

May 20, 2026, 8:30 AM EDT - 3 months ago

Stablecoin Development Earnings release: Q1 2026

Apr 6, 2026, 8:30 AM EDT - 5 months ago

Stablecoin Development Corporation Begins Trading on NYSE American Under Ticker “SDEV”

Mar 23, 2026, 8:30 AM EDT - 5 months ago

NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update

Mar 19, 2026, 7:00 AM EDT - 5 months ago

Stablecoin Development Annual report: Q4 2025

Mar 12, 2026, 2:00 PM EDT - 6 months ago

Stablecoin Development Transcript: EGM 2026

Mar 2, 2026, 7:00 AM EST - 6 months ago

Stablecoin Development Proxy statement: Proxy Filing

Feb 10, 2026, 7:00 AM EST - 7 months ago

Stablecoin Development Proxy statement: Proxy Filing

Jan 30, 2026, 7:00 AM EST - 7 months ago

Stablecoin Development Proxy statement: Proxy Filing

Nov 25, 2025, 7:00 AM EST - 9 months ago

Stablecoin Development Registration statement: Registration Filing

Nov 7, 2025, 4:00 PM EST - 10 months ago

Stablecoin Development Quarterly report: Q3 2025

Oct 20, 2025, 7:07 PM EDT - 10 months ago

NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards

Oct 9, 2025, 8:00 AM EDT - 11 months ago

Stablecoin Development Proxy statement: Proxy Filing

Oct 3, 2025, 8:00 AM EDT - 11 months ago

Stablecoin Development Registration statement: Registration Filing

Sep 23, 2025, 8:00 AM EDT - 11 months ago

Stablecoin Development Proxy statement: Proxy Filing

Sep 18, 2025, 4:30 PM EDT - 11 months ago

NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting

Sep 18, 2025, 8:00 AM EDT - 11 months ago

Stablecoin Development Proxy statement: Proxy Filing

Sep 10, 2025, 8:00 AM EDT - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Aug 26, 2025, 4:05 PM EDT - 1 year ago

NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share

Aug 19, 2025, 5:25 PM EDT - 1 year ago

NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar

Aug 14, 2025, 7:00 AM EDT - 1 year ago

Stablecoin Development Quarterly report: Q2 2025

May 14, 2025, 6:00 PM EDT - 1 year ago

Stablecoin Development Quarterly report: Q1 2025

Apr 2, 2025, 8:00 AM EDT - 1 year ago

Stablecoin Development Annual report: Q4 2024

Mar 19, 2025, 8:00 AM EDT - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Mar 7, 2025, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Mar 7, 2025, 6:50 AM EST - 1 year ago

NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders

Feb 18, 2025, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Feb 4, 2025, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Jan 23, 2025, 8:00 AM EST - 1 year ago

NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal

Jan 23, 2025, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Dec 19, 2024, 6:50 AM EST - 1 year ago

NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders

Dec 18, 2024, 2:00 PM EST - 1 year ago

Stablecoin Development Transcript: EGM 2024

Dec 11, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Dec 9, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Dec 9, 2024, 6:50 AM EST - 1 year ago

NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting

Nov 26, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Nov 22, 2024, 4:05 PM EST - 1 year ago

NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024

Nov 15, 2024, 8:00 AM EST - 1 year ago

Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of its Avenova Brand

Nov 15, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Nov 13, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Nov 12, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Nov 12, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Nov 7, 2024, 4:05 PM EST - 1 year ago

NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results

Nov 7, 2024, 4:00 PM EST - 1 year ago

Stablecoin Development Quarterly report: Q3 2024

Nov 6, 2024, 4:05 PM EST - 1 year ago

NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price

Nov 6, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Oct 29, 2024, 8:00 AM EDT - 1 year ago

NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC

Oct 29, 2024, 8:00 AM EDT - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Oct 16, 2024, 8:00 AM EDT - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Sep 25, 2024, 8:00 AM EDT - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Sep 20, 2024, 8:30 AM EDT - 1 year ago

Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals

Sep 20, 2024, 8:00 AM EDT - 1 year ago

NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets

Sep 20, 2024, 8:00 AM EDT - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Aug 13, 2024, 4:30 PM EDT - 2 years ago

Stablecoin Development Earnings Call Transcript: Q2 2024

Aug 13, 2024, 4:30 PM EDT - 2 years ago

Stablecoin Development Quarterly report: Q2 2024

Aug 13, 2024, 4:05 PM EDT - 2 years ago

NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results

Aug 1, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024

Jul 30, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales

Jul 29, 2024, 4:05 PM EDT - 2 years ago

NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option

Jul 26, 2024, 8:30 AM EDT - 2 years ago

NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering

Jul 25, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Registration statement: Registration Filing

Jul 16, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime Day

Jul 15, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Registration statement: Registration Filing

Jul 11, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million

Jul 10, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Registration statement: Registration Filing

Jul 1, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities

Jun 28, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product Promotions

Jun 21, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Registration statement: Registration Filing

Jun 20, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Registration statement: Registration Filing

Jun 7, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE American

May 29, 2024, 5:22 PM EDT - 2 years ago

NovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate Updates

May 13, 2024, 8:30 AM EDT - 2 years ago

NovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye Symptoms

May 9, 2024, 4:30 PM EDT - 2 years ago

Stablecoin Development Earnings Call Transcript: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Stablecoin Development Quarterly report: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Stablecoin Development Earnings release: Q1 2024

May 9, 2024, 4:05 PM EDT - 2 years ago

NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results

May 7, 2024, 8:00 AM EDT - 2 years ago

NovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through Amazon

May 3, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024

Apr 22, 2024, 6:57 AM EDT - 2 years ago

NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales

Apr 19, 2024, 6:00 PM EDT - 2 years ago

NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity

Apr 18, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Proxy statement: Proxy Filing

Apr 18, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Proxy statement: Proxy Filing

Apr 17, 2024, 6:59 AM EDT - 2 years ago

NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses

Apr 8, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Proxy statement: Proxy Filing

Mar 26, 2024, 4:30 PM EDT - 2 years ago

Stablecoin Development Earnings Call Transcript: Q4 2023

Mar 26, 2024, 4:30 PM EDT - 2 years ago

Stablecoin Development Earnings release: Q4 2023

Mar 26, 2024, 4:30 PM EDT - 2 years ago

Stablecoin Development Annual report: Q4 2023

Mar 26, 2024, 4:05 PM EDT - 2 years ago

NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results

Mar 25, 2024, 6:38 PM EDT - 2 years ago

NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024

Mar 14, 2024, 8:00 AM EDT - 2 years ago

NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023

Jan 30, 2024, 9:00 AM EST - 2 years ago

NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based Sales

Jan 9, 2024, 9:15 AM EST - 2 years ago

NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma's Extensive Distributor Network

SNOA

Dec 6, 2023, 6:50 AM EST - 2 years ago

NovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic Membranes

Nov 9, 2023, 4:30 PM EST - 2 years ago

Stablecoin Development Earnings Call Transcript: Q3 2023

Nov 9, 2023, 4:30 PM EST - 2 years ago

Stablecoin Development Quarterly report: Q3 2023

Nov 9, 2023, 4:05 PM EST - 2 years ago

NovaBay Pharmaceuticals Reports Third Quarter 2023 Financial Results

Nov 2, 2023, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023

Oct 11, 2023, 8:00 AM EDT - 2 years ago

NovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova Programs

Oct 2, 2023, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth Conference

uddin Sep. 8 at 1:52 AM

$SDEV Buying opportunities

0 · Reply

uddin Sep. 5 at 7:10 AM

$SDEV $PWCM Bottom player both will go long way longer 🔥⏰💰

0 · Reply

uddin Sep. 4 at 11:41 PM

$SDEV will flow with $USDE 🔥

0 · Reply

giglio75 Sep. 3 at 2:46 PM

$SDEV 🗯

0 · Reply

uddin Sep. 1 at 3:34 PM

$USDE $SDEV Also more than something 🔥💰

0 · Reply

uddin Sep. 1 at 3:32 PM

$SDEV Hi guys it’s a Diamond stock big buying opportunity 🔥⏰

0 · Reply

Alshma1l Sep. 1 at 1:25 PM

$SDEV sky will hit 0.08-0.09 after 0.07200

0 · Reply

Stockinvestigator420 Aug. 28 at 1:01 AM

$USDE I also picked up some $SDEV. They do SKY tokens. Same shit. Still at the $1 area. USDE is Coke and SDEV is Pepsi…. 😂

0 · Reply

Stockinvestigator420 Aug. 28 at 12:07 AM

$SDEV

0 · Reply

Stock__Hunter Aug. 27 at 2:22 PM

$SDEV bounced off bottom trend yesterday

0 · Reply

birdseyetrader Aug. 24 at 12:53 PM

crypto ripping $WKSP only xrp holding play lets goo next to go like $BTCT.X $SDEV $BMNR $MSTR

1 · Reply

SwingPlayers Aug. 24 at 12:13 PM

Why stablecoin stocks are rallying $BTCT $CRCL $SDEV

0 · Reply

abc12379593827 Aug. 24 at 4:11 AM

$USDE don’t forget about $SDEV

2 · Reply

Bed_ Aug. 24 at 12:16 AM

$SDEV break 1.30 with high volume

0 · Reply

Bridarunaway Aug. 23 at 11:54 PM

$SDEV

0 · Reply

SmalllCapEdge Aug. 22 at 1:22 AM

Glad I sold $GDC at a profits before the rug. $AEHL high 5's to 7$+ $BTOG little runner $SDEV BANGER Getting all profits into $OLOX

3 · Reply

abc12379593827 Aug. 21 at 11:31 PM

$SDEV $SPK.X Someone explain it

0 · Reply

STACKD0E Aug. 21 at 10:12 PM

$CDTG $SDEV $OFAL 👁️

0 · Reply

Alshma1l Aug. 21 at 9:48 PM

$SDEV Sky Resistance 0.09 🔥

0 · Reply

cloudforever Aug. 21 at 9:03 PM

$SDEV why is this one not moving

0 · Reply

SwingPlayers Aug. 21 at 8:48 PM

$USDE Freaking $SDEV shows a chart $95 in Jan. Far cry from $95 today at $1.20

0 · Reply

topstockalerts Aug. 21 at 8:41 PM

$SDEV this one earned a closer look today

0 · Reply

1.0.0